SEC Comment Letter 0000000000-24-010371 to Coherus BioSciences, Inc. (CHRS) (CIK 0001512762) (CHRS)

Coherus BioSciences, Inc. (CHRS) (CIK 0001512762)
Date: Sept. 13, 2024 · CIK: 0001512762 · Accession: 0000000000-24-010371

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-36721

Date

September 13, 2024

Author

Dennis M. Lanfear

Form

UPLOAD

Company

Coherus BioSciences, Inc. (CHRS) (CIK 0001512762)

Letter

September 13, 2024 Dennis M. Lanfear President and Chief Executive Officer Coherus BioSciences, Inc. 333 Twin Dolphin Drive, Suite 600 Redwood City, California 94065 Re:Coherus BioSciences, Inc. Definitive Proxy Statement on Schedule 14A Filed April 15, 2024 File No. 001-36721 Dear Dennis M. Lanfear: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Disclosure Review Program cc:Max Brunner, Esq.

Show Raw Text

September 13, 2024
Dennis M. Lanfear
President and Chief Executive Officer
Coherus BioSciences, Inc.
333 Twin Dolphin Drive, Suite 600
Redwood City, California 94065
Re:Coherus BioSciences, Inc.
Definitive Proxy Statement on Schedule 14A
Filed April 15, 2024
File No. 001-36721
Dear Dennis M. Lanfear:
            We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Disclosure Review Program
cc:Max Brunner, Esq.

SecProbe.io